Amryt Research Limited clinical trials
Acquired by Chiesi Farmaceutici S.p.A., Apr 12, 2023 · source ↗
The registry lists 1 studies whose lead sponsor is Amryt Research Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 20, 2023.
Before and after it joined Chiesi Farmaceutici S.p.A.
- First submitted before Amryt Research Limited became part of Chiesi Farmaceutici S.p.A.
- 1
- First submitted after Amryt Research Limited became part of Chiesi Farmaceutici S.p.A.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Amryt Research Limited1 study
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Chiesi Farmaceutici S.p.A. studies →
- Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis BullosaCompletedNCT03068780Phase 3
Sponsor listed in the registry: Amryt Research Limited · First submitted before Amryt Research Limited became part of Chiesi Farmaceutici S.p.A.